» Articles » PMID: 29933410

Identification of DNA Methylation Prognostic Signature of Acute Myelocytic Leukemia

Overview
Journal PLoS One
Date 2018 Jun 23
PMID 29933410
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study is to find the potential survival related DNA methylation signature capable of predicting survival time for acute myelocytic leukemia (AML) patients.

Methods: DNA methylation data were downloaded. DNA methylation signature was identified in the training group, and subsequently validated in an independent validation group. The overall survival of DNA methylation signature was performed. Functional analysis was used to explore the function of corresponding genes of DNA methylation signature. Differentially methylated sites and CpG islands were also identified in poor-risk group.

Results: A DNA methylation signature involving 8 DNA methylation sites and 6 genes were identified. Functional analysis showed that protein binding and cytoplasm were the only two enriched Gene Ontology terms. A total of 70 differentially methylated sites and 6 differentially methylated CpG islands were identified in poor-risk group.

Conclusions: The identified survival related DNA methylation signature adds to the prognostic value of AML.

Citing Articles

Assessing the Differential Methylation Analysis Quality for Microarray and NGS Platforms.

Budkina A, Medvedeva Y, Stupnikov A Int J Mol Sci. 2023; 24(10).

PMID: 37239934 PMC: 10218268. DOI: 10.3390/ijms24108591.


A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer.

Li M, Zhu C, Xue Y, Miao C, He R, Li W Br J Cancer. 2023; 128(9):1681-1689.

PMID: 36828869 PMC: 10133253. DOI: 10.1038/s41416-023-02155-8.


Systematic review of epigenetic targets in acute myeloid leukemia.

Verma S, Dhanda H, Singh A, Rishi B, Tanwar P, Chaudhry S Am J Blood Res. 2021; 11(5):458-471.

PMID: 34824880 PMC: 8610793.


DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML).

Krali O, Palle J, Backlin C, Abrahamsson J, Noren-Nystrom U, Hasle H Genes (Basel). 2021; 12(6).

PMID: 34200630 PMC: 8229099. DOI: 10.3390/genes12060895.


Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML.

Modarres P, Mohamadi Farsani F, Nekouie A, Vallian S Sci Rep. 2021; 11(1):12485.

PMID: 34127725 PMC: 8203646. DOI: 10.1038/s41598-021-91864-2.


References
1.
Deneberg S, Grovdal M, Karimi M, Jansson M, Nahi H, Corbacioglu A . Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia. 2010; 24(5):932-41. DOI: 10.1038/leu.2010.41. View

2.
Tse K, Su W, Chang K, Tsang N, Yu C, Tang P . Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet. 2009; 85(2):194-203. PMC: 2725267. DOI: 10.1016/j.ajhg.2009.07.007. View

3.
Dohner H, Weisdorf D, Bloomfield C . Acute Myeloid Leukemia. N Engl J Med. 2015; 373(12):1136-52. DOI: 10.1056/NEJMra1406184. View

4.
Yoshinaga S, Mabuchi K, Sigurdson A, Doody M, Ron E . Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies. Radiology. 2004; 233(2):313-21. DOI: 10.1148/radiol.2332031119. View

5.
Wolters J, van Breda S, Claessen S, de Kok T, Kleinjans J . Data on novel DNA methylation changes induced by valproic acid in human hepatocytes. Data Brief. 2017; 16:161-171. PMC: 5702865. DOI: 10.1016/j.dib.2017.11.031. View